Covered recipient · General Payments record
COREY GALLUS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$5,179.30
- Reported across 307 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $491.98 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $205.44 | 10 |
| Novo Nordisk AS | $90.10 | 5 |
| Abbott Laboratories | $66.53 | 4 |
| Astellas Pharma US Inc | $41.47 | 2 |
| Amgen Inc. | $36.92 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $19.61 | 1 |
| GlaxoSmithKline, LLC. | $17.86 | 1 |
| DEXCOM, INC. | $14.05 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $14.60 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125073810 | CMS |
| Abbott Laboratories | $16.31 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125073812 | CMS |
| Abbott Laboratories | $18.53 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125073814 | CMS |
| Abbott Laboratories | $17.09 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125073816 | CMS |
| ABBVIE INC. | $12.86 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103767750 | CMS |
| ABBVIE INC. | $18.26 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103767752 | CMS |
| ABBVIE INC. | $23.11 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103767754 | CMS |
| ABBVIE INC. | $13.61 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103767756 | CMS |
| ABBVIE INC. | $32.94 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103767758 | CMS |
| ABBVIE INC. | $32.87 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103767760 | CMS |
| ABBVIE INC. | $25.76 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103767762 | CMS |
| ABBVIE INC. | $12.77 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103767764 | CMS |
| ABBVIE INC. | $12.65 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103767766 | CMS |
| ABBVIE INC. | $20.61 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103767768 | CMS |
| Amgen Inc. | $19.58 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111579703 | CMS |
| Amgen Inc. | $17.34 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117256629 | CMS |
| Astellas Pharma US Inc | $19.44 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139333548 | CMS |
| Astellas Pharma US Inc | $22.03 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139440880 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $19.61 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086174538 | CMS |
| Dexcom, Inc. | $14.05 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153293141 | CMS |
| GlaxoSmithKline, LLC. | $17.86 | 07/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116152193 | CMS |
| Novo Nordisk Inc | $16.67 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097164436 | CMS |
| Novo Nordisk Inc | $19.60 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097783539 | CMS |
| Novo Nordisk Inc | $18.29 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096986981 | CMS |
| Novo Nordisk Inc | $13.24 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096827802 | CMS |
| Novo Nordisk Inc | $22.30 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096671545 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.